Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
85.4M
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
57M
-
Shares change
-
+24.8K
-
Total reported value, excl. options
-
$213M
-
Value change
-
+$726K
-
Put/Call ratio
-
1.03
-
Number of buys
-
67
-
Number of sells
-
-63
-
Price
-
$3.74
Significant Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q2 2023
161 filings reported holding AVIR - Atea Pharmaceuticals, Inc. - COMMON STOCK as of Q2 2023.
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57M shares
of 85.4M outstanding shares and own 66.77% of the company stock.
Largest 10 shareholders include FMR LLC (8.5M shares), BlackRock Inc. (7.71M shares), EcoR1 Capital, LLC (7M shares), VANGUARD GROUP INC (4.52M shares), TANG CAPITAL MANAGEMENT LLC (3.03M shares), Bain Capital Life Sciences Investors, LLC (2.49M shares), BML Capital Management, LLC (2.24M shares), GEODE CAPITAL MANAGEMENT, LLC (1.65M shares), Cormorant Asset Management, LP (1.55M shares), and STATE STREET CORP (1.53M shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.